Bavarian Nordic — Februar 2020
-
-
Coronavirus: Gilead’s Remdesivir Begins Trials as Researchers Publish Positive In Vitro Results
Clinical trials of Gilead Sciences’ remdesivir have begun in Wuhan, China, the center of the novel coronavirus outbreak, a day after Chinese researchers recommended that the antiviral drug candidate remdesivir be assessed in humans as a potential treatment for 2019-nCoV.
GEN - Genetic Engineering and Biotechnology News (www.genengnews.com)
-
-
God morgen.
-
-
Sanofi melder sig på banen omkring covid-19 vaccine https://medwatch.dk/secure/Medicinal___Biotek/article11950785.ece
-
Her en fin artikel om udvikling af medicin mod MERS, Ebola og senest COVID-19 https://endpts.com/he-built-a-mers-treatment-in-6-months-and-then-the-best-ebola-drug-now-christos-kyratsous-turns-his-sights-on-covid-19/
-
KayKay Mercks ebola vaccine virker helt anderledes end J&J/BNs. Mercks bruges når folk har fået ebola (therapeutisk) mens BNs bruges som forebyggende (profilaktisk). Så det er svært at sammenligne. Og derfor kan man ikke sige at de er bagud
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind